Combination therapy overcomes BET inhibitor resistance, shows study

bySt. Jude Children's Research HospitalStudy first author Shaela Fields (Wright), from the lab of Chunliang, Li, PhD, St. Jude Department of Tumor Cell Biology, led research to understand BE

Updated on: January 16,2024

Combination therapy overcomes BET inhibitor resistance, shows study

bySt. Jude Children's Research HospitalStudy first author Shaela Fields (Wright), from the lab of Chunliang, Li, PhD, St. Jude Department of Tumor Cell Biology, led research to understand BE

Updated on:January 16,2024

Trial: Standard chemoradiation superior to de-intensification approaches for HPV-related oropharyngeal cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainResearchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal canc

Updated on: October 22,2024

Trial: Standard chemoradiation superior to de-intensification approaches for HPV-related oropharyngeal cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainResearchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal canc

Updated on:October 22,2024

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study

by Impact Journals LLCLung adenocarcinoma histochemistry. Representative sections illustrating tumor HA histochemistry staining (Ventana HA RxDx Assay) in FFPE lung adenocarcinoma samples scored as HA

Updated on: January 23,2024

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study

by Impact Journals LLCLung adenocarcinoma histochemistry. Representative sections illustrating tumor HA histochemistry staining (Ventana HA RxDx Assay) in FFPE lung adenocarcinoma samples scored as HA

Updated on:January 23,2024

Immune targets for chemotherapy-resistant breast cancers identified

byKing's College LondonAnalysis of stromal TILs in residual disease and prognostic implications. A) Kaplan–Meier curves for i) progression free survival and ii) overall survival in ER+HER2-

Updated on: January 02,2024

Immune targets for chemotherapy-resistant breast cancers identified

byKing's College LondonAnalysis of stromal TILs in residual disease and prognostic implications. A) Kaplan–Meier curves for i) progression free survival and ii) overall survival in ER+HER2-

Updated on:January 02,2024

Researchers develop new one-two punch against melanoma in mouse model

by Johns Hopkins University School of MedicineCredit: Kimmel Cancer CenterResearchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University

Updated on: June 04,2024

Researchers develop new one-two punch against melanoma in mouse model

by Johns Hopkins University School of MedicineCredit: Kimmel Cancer CenterResearchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University

Updated on:June 04,2024

Expert second opinion improves reliability of melanoma diagnoses

by University of California, Los AngelesCredit: CC0 Public DomainGetting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist&#3

Updated on: April 07,2024

Expert second opinion improves reliability of melanoma diagnoses

by University of California, Los AngelesCredit: CC0 Public DomainGetting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist&#3

Updated on:April 07,2024

New machine learning model improves prediction of prostate cancer recurrence

byElsevierCredit: Pixabay/CC0 Public DomainPredicting the course of prostate cancer is challenging because only a fraction of prostate cancer patients experience recurrence after radical prostat

Updated on: January 11,2024

New machine learning model improves prediction of prostate cancer recurrence

byElsevierCredit: Pixabay/CC0 Public DomainPredicting the course of prostate cancer is challenging because only a fraction of prostate cancer patients experience recurrence after radical prostat

Updated on:January 11,2024

Researchers accurately predict how well body will fight lung cancer based on patterns of immune cells

by Case Western Reserve UniversityActual photographs of the shape of the cancer-associated immune cells. Credit: Case Western Reserve UniversityResearchers at Case Western Reserve University have

Updated on: March 01,2024

Researchers accurately predict how well body will fight lung cancer based on patterns of immune cells

by Case Western Reserve UniversityActual photographs of the shape of the cancer-associated immune cells. Credit: Case Western Reserve UniversityResearchers at Case Western Reserve University have

Updated on:March 01,2024

New blood test developed to diagnose ovarian cancer

by Brigham and Women's HospitalIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epitheliu

Updated on: April 14,2024

New blood test developed to diagnose ovarian cancer

by Brigham and Women's HospitalIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epitheliu

Updated on:April 14,2024

Study: Mitochondria engage the integrated stress response to promote tumor growth

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper, titled "Mitochondria engage the integrated stress response to promote tumor growth," was published inOncot

Updated on: January 30,2024

Study: Mitochondria engage the integrated stress response to promote tumor growth

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper, titled "Mitochondria engage the integrated stress response to promote tumor growth," was published inOncot

Updated on:January 30,2024

Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications

Updated on: March 12,2024

Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications

Updated on:March 12,2024

First-line regimens with endocrine therapy show benefits in breast cancer

by Lori SolomonFirst-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-posi

Updated on: February 03,2024

First-line regimens with endocrine therapy show benefits in breast cancer

by Lori SolomonFirst-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-posi

Updated on:February 03,2024